Riskpilot← Back to searchSign inGet full accessSELLEBAKK SYNSSENTER AS
ASActiveOrg 995116855Løenveien 5, 1653 SellebakkRetail sale of medical and orthopaedic goods · NACE 4774Est. 201011 employees
Revenue 2024
NOK 11,4M
+7% vs 2023
EBITDA margin
11.6%
+13% vs 2023
Equity ratio
62.5%
Financial strength
Net profit 2024
NOK 1M
+18% vs 2023
| Revenue | NOK 11,4M | +7% |
| EBITDA | NOK 1,3M | +13% |
| Net profit | NOK 1M | +18% |
| Total assets | NOK 5,1M | +24% |
| Equity | NOK 3,2M | +38% |
| Employees | 11 | — |
Legal name
SELLEBAKK SYNSSENTER AS
Org number
995116855
Legal form
Aksjeselskap
NACE code
4774 · Retail sale of medical and orthopaedic goods
Founded
3. februar 2010
Share capital
NOK 100 000
Employees
11 (FTE)
VAT registered
Yes
Audit selected
No
Last report
2024-12-31
Financial year
January – December
Signatory rights
Styrets leder alene. daglig leder alene.
Company purpose
Kjøp og salg av varer og tjenester vedrørende optikk og optisk utstyr.
Address
Løenveien 5, 1653 Sellebakk
Phone
+4769365700
Email
mail@sellebakksynssenter.no
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Revenue | 8 484 | 10 260 | 10 684 | 10 636 | 11 405 |
| Staff expenses | −2 940 | −3 802 | −4 300 | −4 672 | −4 944 |
| EBITDA | 1 933 | 2 025 | 1 743 | 1 166 | 1 321 |
| Depreciation & amort. | −34 | −24 | −33 | −62 | −58 |
| EBIT | 1 900 | 2 001 | 1 710 | 1 104 | 1 263 |
| Net financials | 5 | 3 | 9 | 24 | 68 |
| Profit before tax | 1 904 | 2 004 | 1 719 | 1 128 | 1 331 |
| Tax | 417 | 438 | 374 | 243 | 288 |
| Net profit | 1 488 | 1 566 | 1 345 | 885 | 1 043 |
| Item | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|
| Total assets | 3 737 | 3 576 | 3 532 | 4 112 | 5 103 |
| Equity | 1 279 | 1 845 | 1 640 | 2 310 | 3 189 |
| Long-term debt | 0 | 0 | 0 | 0 | 0 |
| Short-term debt | 2 458 | 1 731 | 1 891 | 1 801 | 1 914 |
| Total debt | 2 458 | 1 731 | 1 891 | 1 801 | 1 914 |
EBITDA margin
11.6%
This company
15.8%
Market median
-27% vs market
20202024
Equity ratio
62.5%
This company
38.2%
Market median
+64% vs market
20202024
Return on equity
32.7%
This company
18.4%
Market median
+78% vs market
20202024
Net profit margin
9.1%
This company
8.1%
Market median
+12% vs market
20202024
Asset turnover
2.23×
This company
1.12×
Market median
+99% vs market
20202024
Debt / equity
0.60×
This company
0.62×
Market median
+3% vs market
20202024
- Annual report 2024Filed via Brønnøysundsregistrene · Period 2024-01-01 – 2024-12-31
- Annual report 2023Filed via Brønnøysundsregistrene · Period 2023-01-01 – 2023-12-31
- Annual report 2022Filed via Brønnøysundsregistrene · Period 2022-01-01 – 2022-12-31
- Annual report 2021Filed via Brønnøysundsregistrene · Period 2021-01-01 – 2021-12-31
- Annual report 2020Filed via Brønnøysundsregistrene · Period 2020-01-01 – 2020-12-31
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
LJ Chief Executive Officer | Chief Executive Officer | 2010 |
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
| Chairman | 2010 | |
| Shareholder | Type | Ownership | Votes | Since |
|---|---|---|---|---|
| Company | 100% | 100% | 2024 |
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
Syn-Holding As
SELLEBAKK SYNSSENTER AS Board members of SELLEBAKK SYNSSENTER AS also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Lene Johannesen | Chief Executive Officer | 0 companies |
| Trond Erik Johannesen | Chairman | 0 companies |